Convexity Labs

CCCS

Convexity Analyst · CCCS
Speculativemedium confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: CCCS (CCC Intelligent Solutions Holdings Inc.) Date: 2026-06-13 Current Price: $8.75

1. Structural Readiness

State: Context-only Conservative Entry: — (Awaiting confirmed breakout) Aggressive/Pre-Breakout Entry: — (Not actionable on setup alone) Breakout Level: — (Requires confirmation of price action above the forming range high) Current Price: $8.75 Extension:ATR Current: 3.2% (Productive)

Setup Analysis:

2. Thesis Layer

Thesis Classification: TACTICAL / SETUP-LED Secular Thesis: None named at this date.

This is a tactical, setup-led name. There is no named macro or secular thesis driving the immediate conviction stack. The investment case must be judged strictly on the quality of the technical setup (which is currently forming) and the underlying business fundamentals. No external narrative or thematic exposure should be assumed or invented to support the position. The conviction relies entirely on the execution of the business model and the resolution of the current price structure.

3. The Business

Company Overview: CCC Intelligent Solutions Holdings Inc. operates as a Software-as-a-Service (SaaS) provider within the Property and Casualty (P&C) insurance sector. The company delivers advanced cloud, mobile, artificial intelligence (AI), telematics, and hyperscale technologies designed to digitize vital workflows and link participants across the insurance ecosystem.

Business Model & Segments: The company generates revenue through its SaaS platform, which facilitates commercial transactions and connects insurers, repair facilities, and other ecosystem participants. Its solutions are categorized into four primary segments:

  • CCC Insurance: Solutions for the insurance side of the ecosystem.
  • CCC Repair: Solutions for the repair facility side.
  • CCC Other Ecosystem: Additional ecosystem connectivity tools.
  • CCC International: Global expansion of its core solutions.

Fundamental Evidence (as of 2026-04-30):

  • Revenue Growth: In Q1 2026, total revenue grew 12% year-over-year to $281 million, exceeding the high end of management guidance.
  • Profitability: Adjusted EBITDA reached $120 million, also above the high end of guidance. The adjusted EBITDA margin expanded approximately 300 basis points year-over-year to 43%.
  • AI Contribution: AI-based solutions drove approximately one-third of the overall year-over-year growth, expanding at roughly 3.5x the total company growth rate.
  • Customer Base: The company serves 27 of the top 30 U.S. auto insurers by 2024 Direct Written Premium and major repair facility chains.
  • Contract Renewals: In April 2026, the company signed a multiyear agreement with Allstate for their third-party casualty business. Additionally, one of the top 5 U.S. auto insurers renewed and extended its partnership via a new multiyear enterprise agreement.
  • Market Dynamics: Management notes that over the past decade, personal auto claim counts have declined by less than 1% annually, while average dollars per claim have grown approximately 6% annually, driving ~5% annual growth in total claims dollars paid. This structural trend supports the demand for CCC's digitization and AI tools.

Forward Guidance (Management Expectations): For the full year 2026, management expects total revenue of $1.155 billion to $1.163 billion, representing approximately 10% year-over-year growth at the midpoint.

4. Archetype and Conviction

Archetype: Quality Compounder / Margin Inflector Rationale: The company fits the Quality Compounder archetype due to its high-margin SaaS model (43% adjusted EBITDA margin) and recurring revenue base. It simultaneously exhibits Margin Inflector characteristics, evidenced by the 300 basis point expansion in EBITDA margins and the high growth rate of its AI segment (3.5x total growth). The business is not a deep value recovery or a cyclical play; it is a structural growth story driven by the digitization of the P&C claims process.

Valuation & Conviction Stack:

  • Thesis Strength: Moderate. The thesis is tactical and setup-led, lacking a named macro driver. However, the fundamental execution is strong.
  • Evidence Quality: High. The earnings transcript provides specific, quantified data on revenue beats, margin expansion, and AI contribution.
  • Structural Quality: Strong. The customer concentration (top 30 insurers) and high renewal rates suggest high switching costs and sticky revenue.
  • Setup Readiness: Partial. The setup is FORMING. The price is holding above the support line, but the breakout has not occurred. This limits immediate conviction compared to a confirmed breakout.
  • Rerating Potential: Moderate to High. The combination of double-digit revenue growth, expanding margins, and the AI narrative (driving 1/3 of growth) provides a clear path for multiple expansion if the technical breakout confirms.

Financial Spine Context: Forward consensus EPS for FY1 is $0.41283 and FY2 is $0.46541. The financial spine coverage is "complete," providing a baseline for valuation assessment, though the current price of $8.75 implies a specific multiple that must be weighed against the 10% growth guidance.

5. Invalidation, Strengthening, and Gaps

What Would Invalidate the Case:

  • Fundamental: A miss on the full-year 2026 revenue guidance ($1.155B–$1.163B) or a contraction in the adjusted EBITDA margin below 43%.
  • Customer: Loss of a major contract (e.g., Allstate or a top 5 insurer) or a significant slowdown in AI-driven growth.

What Would Strengthen the Case:

  • Technical: A confirmed breakout above the consolidation range high with volume, transitioning the setup from "Forming" to "Confirmed-Active."
  • Fundamental: Continued acceleration in AI-driven revenue contribution or further margin expansion beyond the 43% level.
  • Strategic: Announcement of new enterprise agreements with additional top-tier insurers.

Gaps in Evidence:

  • Cash Flow: While EBITDA is provided, specific free cash flow conversion metrics for Q1 2026 are not detailed in the provided evidence.
  • International Growth: The specific growth rate of the "CCC International" segment is not quantified in the provided transcript excerpts.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Q1 revenue grew 12% to $281M beating guidance; Adjusted EBITDA margin expanded 300bps to 43%; AI solutions drove 1/3 of growth at 3.5x the company rate; Full year 2026 revenue guidance of $1.155B-$1.163B (10% growth). Key risks: Technical setup is forming but not confirmed (no breakout fired); Lack of named secular thesis limits conviction stack; High valuation multiple implied by current price relative to EPS guidance; Potential for margin compression if AI investment costs outpace revenue. Sizing hint: Position size should be conservative given the "forming" status; treat as a watch-list candidate awaiting confirmation. Expected path: Management expects 10% revenue growth for 2026; if the technical breakout occurs, the setup transitions to active, allowing for a re-rating based on the AI growth narrative. Expected horizon: 3 to 6 months for the technical setup to resolve (breakout or invalidation).

Loading chart...
Exhibit 1: CCCS daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for CCCS.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for CCCS.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: